GOP lawmakers plan new bill to temporarily ban contraceptive

11/18/2004 | Washington Times, The

The legislation would suspend the sale of RU-486 while the Government Accountability Office conducts a six-month review of the process leading to FDA approval. One co-sponsor said questions remain about the FDA's approval of the drug, also known as mifepristone, under a protocol intended to deal with drugs treating life-threatening diseases. The action comes in light of the deaths of three U.S. women after taking the drug, but an FDA official said the agency has no evidence RU-486 caused the deaths.

View Full Article in:

Washington Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ